Blood test may identify lung cancer patients likely to respond to erlotinib
Friday, April 30, 2010 - 13:11
in Health & Medicine
Testing for the presence of specific cancer protein 'fingerprints' in the blood of lung cancer patients may be a useful means of identifying a subgroup whose tumors are more likely to shrink when...